Rb1/105 gene alterations and head and neck carcinogenesis

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The Retinoblastoma gene (Rb1) is a critical tumor suppressor involved in cell cycle regulation.
• Abnormalities in cell cycle genes, including Rb1, are implicated in head and neck cancer (HNC).
• Limited data exists on Rb1 gene aberrations in the Pakistani population concerning HNC.

Purpose of the Study:

• To investigate genetic aberrations of the Rb1 gene in Pakistani HNC patients.
• To determine the association between Rb1 mutations and HNC development in this demographic.
• To identify novel mutations within the Rb1 gene in the Pakistani population.

Main Methods:

• Genomic DNA was extracted from 300 HNC patients and 270 controls.
• The salient coding region of the Rb1 gene was amplified using Polymerase Chain Reaction (PCR).
• Mutational screening was performed using Single Strand Confirmation Polymorphism (SSCP) followed by sequence analysis.

Main Results:

• Five missense mutations, two frameshift mutations, two stop codons, and two intronic substitutions were identified.
• The overall mutation frequency was 0.71.
• Novel missense mutations, a frameshift mutation, and a Lys462stop nonsense mutation were reported in Pakistani HNC patients.

Conclusions:

• Rb1 germline mutations may contribute to genetic susceptibility for HNC in the Pakistani population.
• This is the first report suggesting an association between Rb1 gene mutations and HNC risk in Pakistan.
• Further research is warranted to elucidate the role of Rb1 in HNC pathogenesis in this region.